Press Kit

Our Mission

Our mission is to help people with chronic pain live their best lives. We are committed to empowering people to reclaim their lives from chronic pain and believe that technology can play a central role. We combine advanced neurostimulation with innovative design to bring high technology, high quality pain relief solutions to people suffering from chronic pain. Meet our management team.

Chronic Pain Facts

Chronic pain is defined as pain on most days for at least 3 months

50M to 100M> US adults have chronic pain (source: CDC, Institute of Medicine)

Chronic pain costs the US $600B annually (source: Institute of Medicine)

There were 170M opioid prescriptions in the US in 2018, which is 1 prescription for every 2 people living in the country (source: CDC).

51% of people with chronic pain report having little or no control over their pain (source: American Pain Foundation 2006, Voices of Chronic Pain)

77% of people with chronic pain report feeling depressed (source: American Pain Foundation 2006, Voices of Chronic Pain)

86% of people with chronic pain are unable to sleep well (source: American Pain Foundation 2006, Voices of Chronic Pain)

Quell Facts

Wearable device that relieves chronic leg, foot and knee pain

Drug free, non-invasive and does not involve surgery

Based on transcutaneous electrical nerve stimulation (TENS) which has been prescribed by physicians for chronic pain for decades

Prescription strength nerve stimulation, Quell is the most advanced TENS device available

Automated, personalized pain relief with patented Therapy Autopilot™

Only TENS device cleared by FDA for use during sleep

Device controlled and enhanced by the Quell Relief mobile app for iOS and Android

Available over-the-counter, does not require a prescription

Covered by 14 US utility patents

Designed and assembled in the USA, over 200,000 devices shipped

Recent Press Releases

NeuroMetrix to Target Chronic Knee Pain with Quell® 2.0 Wearable Pain Relief Device

NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia

NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update

NeuroMetrix Reports Scientific Presentations at the American Academy of Pain Medicine 2020 Annual Meeting

NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology

Recent Media Coverage*

Pain Medicine News Wearable TENS Device Improves Sleep While Relieving Knee Pain

CNET Chronic pain relief without drugs: 8 products to try

Practical Pain Management Pain Therapy Options for the Home

Recent Awards

Logo Files

Collateral

Quell 2.0 Quick Start Guide

Download

Quell 2.0 User Manual

Download

Chronic Pain and Opioid Crisis - Flipping the Script

Download

Product Photography

Download the Photograph

Download the photograph

Download the Photograph

Product Videos

Setting up Quell

Embed Code: <iframe width="480" height="270" src="https://www.youtube.com/embed/oYFJ6f5RY0s" frameborder="0" allow="autoplay; encrypted-media" allowfullscreen></iframe>

Quell's Unique Therapy Personalization

Embed Code: <iframe width="480" height="270" src="https://www.youtube.com/watch?v=wLy3Rd1AFAg" frameborder="0" allow="autoplay; encrypted-media" allowfullscreen></iframe>

Bruce Describes how Quell Improved his Life

Embed Code: <iframe width="480" height="270" src="https://www.youtube.com/watch?v=ohWaec9nMZM" frameborder="0" allow="autoplay; encrypted-media" allowfullscreen></iframe>